Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-19T12:33:03.315Z Has data issue: false hasContentIssue false

Thyroid cancer: is ethnicity relevant?

Published online by Cambridge University Press:  04 May 2011

T Galm*
Affiliation:
ENT Department, Heartlands Hospital, Birmingham, UK
S Minhas
Affiliation:
ENT Department, Walsall Manor Hospital, Walsall, UK
R J Cullen
Affiliation:
ENT Department, Russells Hall Hospital, Dudley, UK
H Griffiths
Affiliation:
ENT Department, Heartlands Hospital, Birmingham, UK
*
Address for correspondence: Ms Tira Galm, Heartlands Hospital, Bordesley Green, Birmingham B9 5ST, UK E-mail: [email protected]

Abstract

Objective:

This study aimed to determine the age at which various ethnic groups present with thyroid cancer.

Method:

Retrospective, observational study based at three district general hospitals in the West Midlands, serving a widely diverse ethnic population. We assessed all patients undergoing an operative or core biopsy procedure for a thyroid nodule from 1 January 1998 to 31 December 2009. Only patients diagnosed with thyroid cancer were included. Variables examined included the patient's ethnic origin, sex and age at presentation.

Result:

We identified 263 patients diagnosed with thyroid cancer. Papillary carcinoma predominated. Ethnicity was categorised as Caucasian, Asian, black or other. Thyroid cancer was predominantly seen in women, in all ethnic groups. The mean age of thyroid cancer presentation was 50 years in Asians and 56 years in Caucasians, for both sexes combined. The mean presentation age of Asian women was significantly younger (46 years) than that of Caucasian women (56 years) (p = 0.01).

Conclusion:

In this population, Asian women presented with thyroid cancer at a significantly younger mean age than Caucasian women.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Leese, GP, Flynn, RV, Jung, RT, Macdonald, TM, Murphy, MJ, Morris, AD. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol 2008;68:311–16CrossRefGoogle ScholarPubMed
2Mitchell, I, Livingston, EH, Chang, AY, Holts, S, Snyder, WH 3rd, Lingvay, I et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 2007;142:823–8CrossRefGoogle ScholarPubMed
3Haselkorn, T, Bernstein, L, Preston-Martin, S, Cozen, W, Mack, WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 2000;2:163–70CrossRefGoogle Scholar
4Spitz, MR, Sider, JG, Katz, RL, Olacks, ES, Newell GR Ethnic patterns of thyroid cancer incidence in the United States. Int J Cancer 1988;15:549–53CrossRefGoogle Scholar
5Rossing, MA, Schwartz, SM, Weiss, NS. Thyroid cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 1995;6:439–44CrossRefGoogle Scholar
7Schwartz, KL, Kulwicki, A, Weiss, LK, Fakhouri, H, Sakr, W, Kau, G et al. Cancer among Arab Americans in the metropolitan Detroit area. Ethn Dis 2004;14:141–6Google ScholarPubMed
8Haselkorn, T, Stewart, SL, Horn-Ross, PL. Why are thyroid cancer rates so high in Southeast Asian Women living in the United States? The Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:144150Google ScholarPubMed
9Winter, H, Cheng, KK, Cummins, C, Maric, R, Silcocks, P, Varghese, C. Latest trends in cancer incidence among UK South Asains in Leicester. Br J Cancer 1999;79:645–54CrossRefGoogle Scholar
10Knobles, M, Medeiros-Neto, G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer [in English and Portuguese]. Arq Bras Endocrinol Metabol 2007;51:701–12Google Scholar
11Franceschi, S. Iodine intake and thyroid carcinoma – a potential risk factor. Exp Clin Endocrinol Diabetes 1998;106(suppl 3):S3844CrossRefGoogle ScholarPubMed
12Grieco, M, Santoro, M, Berlingieri, MG, Melillo, RM, Donghi, R, Bongarzone, I et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990;60:557–63CrossRefGoogle ScholarPubMed
13Jhiang, SM, Sargartz, JE, Tong, Q, Parker-Thornburg, J, Capen, CC. Targeted expression of the RET/PTCI oncogene induces papillary thyroid carcinoma. Endocrinology 1994;6:1119Google Scholar
14Nasseri, K. Thyroid cancer in the Middle Eastern population of California. Cancer Causes Control 2008;19:1183–91CrossRefGoogle ScholarPubMed